Omnicell, Inc (OMCL) concluded trading on Wednesday at a closing price of $28.27, with 0.49 million shares of worth about $13.82 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -38.56% during that period and on June 18, 2025 the price saw a loss of about -0.77%. Currently the company’s common shares owned by public are about 46.84M shares, out of which, 45.28M shares are available for trading.
Stock saw a price change of -6.98% in past 5 days and over the past one month there was a price change of 1.51%. Year-to-date (YTD), OMCL shares are showing a performance of -36.50% which increased to 1.29% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $22.66 but also hit the highest price of $55.74 during that period. The average intraday trading volume for Omnicell, Inc shares is 683.09K. The stock is currently trading -5.21% below its 20-day simple moving average (SMA20), while that difference is down -4.71% for SMA50 and it goes to -27.74% lower than SMA200.
Omnicell, Inc (NASDAQ: OMCL) currently have 46.84M outstanding shares and institutions hold larger chunk of about 101.31% of that.
The stock has a current market capitalization of $1.32B and its 3Y-monthly beta is at 0.78. PE ratio of stock for trailing 12 months is 62.21, while it has posted earnings per share of $0.45 in the same period. It has Quick Ratio of 1.21 while making debt-to-equity ratio of 0.31. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OMCL, volatility over the week remained 1.19% while standing at 2.59% over the month.
Stock’s fiscal year EPS is expected to drop by -24.26% while it is estimated to increase by 17.98% in next year. EPS is likely to grow at an annualized rate of -2.76% for next 5-years, compared to annual growth of -28.29% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on May 14, 2025 offering an Overweight rating for the stock and assigned a target price of $35 to it. Coverage by BofA Securities stated Omnicell, Inc (OMCL) stock as a Neutral in their note to investors on October 31, 2024, suggesting a price target of $57 for the stock. On August 02, 2024, Barclays Upgrade their recommendations, while on January 03, 2024, Barclays Initiated their ratings for the stock with a price target of $33. Stock get an Equal weight rating from Wells Fargo on November 03, 2023.
